SILVER
Quality Assistance
Quality Assistance’s goal is to accelerate people’s access to new medicines and is committed to providing pharmaceutical and biopharmaceutical companies with all the analytical services required by EMA and FDA regulations for the development and marketing of their innovative medicinal products.
Meet Louis Lefebvre and Rémy Delmotte, Key Account Managers, on booth A22. Damien Mouvet and Pedro Alves, Scientific Managers, will also attend the congress. Make sure to exchange with them on the latest Gene and Cell Therapy trends and discuss your analytical needs.
Quality Assistance is a leading analytical CRO and expert in…
Throughout non-clinical and clinical development, our experts provide you with the customised solutions in terms of analytical protocols and innovative technologies to help you move your product from discovery to the market place.
With extensive experience in the analysis of innovative products and thanks to a continuous investment in new technologies and machinery, Quality Assistance can assist you in the development of your recombinant Adeno-Associated Viral Vectors (rAAVs) products from early phases to commercialisation.
Building on its considerable experience in the analysis of complex innovative drugs, Quality Assistance is continuously advancing ways to support the development of your mRNA-based therapeutics and expanding its related machinery and equipment.
Whatever the type of antigen, Quality Assistance covers a wide range of analytical technologies needed to support vaccine development, including product characterisation, development and validation of analytical methods, stability studies, batch testing and bioanalytical services to support immunogenicity and protection studies.
Meet Quality Assistance there!
© 2024 European Society of Gene and Cell Therapy